2012
DOI: 10.1016/j.amjcard.2012.08.022
|View full text |Cite
|
Sign up to set email alerts
|

Von Willebrand Factor and the Right Ventricle (the MESA-Right Ventricle Study)

Abstract: Elevation in plasma activity of von Willebrand Factor (vWF) reflects endothelial dysfunction and predicts death in pulmonary arterial hypertension (PAH). Higher vWF activity is also associated with lower right ventricular (RV) ejection fraction in PAH. Little is known about the relationship between vWF and RV structure and function in adults without cardiovascular disease. In the current investigation, we included 1,976 participants with MRI assessment of RV structure and function and measurement of vWF activi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 30 publications
0
2
1
Order By: Relevance
“…The results of our study, namely, that increased vascular stiffness markers were generally associated with smaller RV volumes and lower RV mass , were contrary to our original hypotheses, which was based on observations of the response of RV in the setting of HFpEF . It is notable that previous investigations in MESA‐RV have similarly revealed relationships between smaller RV size and aging, risk of incident dyspnea, emphysema/chronic obstructive pulmonary disease, and inflammatory biomarkers . Our findings serve as a caution to extrapolating information from disease states to preclinical stages of disease given that the consistency between inflammatory biomarkers and vascular stiffness and decreased RV size imply distinct pathophysiological processes in individuals without clinical cardiovascular disease.…”
Section: Discussioncontrasting
confidence: 99%
“…The results of our study, namely, that increased vascular stiffness markers were generally associated with smaller RV volumes and lower RV mass , were contrary to our original hypotheses, which was based on observations of the response of RV in the setting of HFpEF . It is notable that previous investigations in MESA‐RV have similarly revealed relationships between smaller RV size and aging, risk of incident dyspnea, emphysema/chronic obstructive pulmonary disease, and inflammatory biomarkers . Our findings serve as a caution to extrapolating information from disease states to preclinical stages of disease given that the consistency between inflammatory biomarkers and vascular stiffness and decreased RV size imply distinct pathophysiological processes in individuals without clinical cardiovascular disease.…”
Section: Discussioncontrasting
confidence: 99%
“…Other mechanisms that reduce blood return to the thorax in severe COPD, affecting filling of both ventricles and the pulmonary vasculature, include a reduced gradient in pressure between the abdomen and chest and abnormal diaphragm orientation compressing the vena cava (42). Alternatively, intrinsic RV diastolic dysfunction, possibly related to increased inflammation or endothelial dysfunction, could decrease RV filling (43, 44). These novel mechanisms may suggest innovative approaches which target diastolic function (for example, soluble guanylate cyclase activators) to treat the cardiac component of exercise limitation in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…Other covariables, including race/ethnicity, height, weight, presence of hypertension or diabetes mellitus, C‐reactive protein (CRP), smoking status, spirometry, and emphysema, were measured as described elsewhere (see appendix, available online) 24 …”
Section: Methodsmentioning
confidence: 99%